These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31756235)

  • 21. γδ T cell receptor deficiency attenuated cardiac allograft vasculopathy and promoted regulatory T cell expansion.
    Zhu H; Li J; Wang S; Liu K; Wang L; Huang L
    Scand J Immunol; 2013 Jul; 78(1):44-9. PubMed ID: 23659436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model.
    Yamada K; Choo JK; Allan JS; Erhorn AE; Menard MT; Mawulawde K; Slisz JK; Aretz HT; Shimizu A; Sachs DH; Madsen JC
    Transplantation; 1999 Aug; 68(4):485-91. PubMed ID: 10480404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.
    Surquin M; Le Moine A; Flamand V; Rombaut K; Demoor FX; Salmon I; Goldman M; Abramowicz D
    Transplantation; 2005 Nov; 80(10):1485-92. PubMed ID: 16340795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation/oxidation in chronic rejection: apolipoprotein a-i mimetic peptide reduces chronic rejection of transplanted hearts.
    Hsieh GR; Schnickel GT; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplantation; 2007 Jul; 84(2):238-43. PubMed ID: 17667816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.
    Shi X; Zhang M; Liu F; Wang Z; Zhang L; Cheng H; Zhang S; Fei T; Guo M; Bian J; Wang Q; Ding G
    Int J Clin Exp Pathol; 2014; 7(2):509-20. PubMed ID: 24551271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haptoglobin enhances cardiac transplant rejection.
    Shen H; Heuzey E; Mori DN; Wong CK; Colangelo CM; Chung LM; Bruce C; Slizovskiy IB; Booth CJ; Kreisel D; Goldstein DR
    Circ Res; 2015 May; 116(10):1670-9. PubMed ID: 25801896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
    Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
    Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preliminary findings in corneal allograft rejection in patients with keratoconus.
    Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J
    Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection.
    Zhao DX; Hu Y; Miller GG; Luster AD; Mitchell RN; Libby P
    J Immunol; 2002 Aug; 169(3):1556-60. PubMed ID: 12133984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
    J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.
    Fritz NM; Stamminger T; Ramsperger-Gleixner M; Kuckhahn AV; Müller R; Weyand M; Heim C
    Transpl Immunol; 2021 Feb; 64():101359. PubMed ID: 33301898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
    Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
    Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell depletion eliminates the development of cardiac allograft vasculopathy in mice rendered tolerant by the induction of mixed chimerism.
    Uehara S; Chase CM; Colvin RB; Madsen JC; Russell PS
    Transplant Proc; 2006 Dec; 38(10):3169-71. PubMed ID: 17175214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-37 contributes to endometrial regenerative cell-mediated immunotherapeutic effect on chronic allograft vasculopathy.
    Qin Y; Shao B; Ren SH; Ye K; Qin H; Wang HD; Sun C; Zhu Y; Wang Z; Zhang J; Li X; Wang H
    Cytotherapy; 2024 Mar; 26(3):299-310. PubMed ID: 38159090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic rejection of major histocompatibility complex class II-disparate skin grafts after anti-CD3 therapy: a model of antibody-independent transplant vasculopathy.
    Le Moine A; Flamand V; Noël JC; Fayt I; Goldman M; Abramowicz D
    Transplantation; 1998 Dec; 66(11):1537-44. PubMed ID: 9869097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rantes production during development of cardiac allograft vasculopathy.
    Yun JJ; Fischbein MP; Laks H; Irie Y; Espejo ML; Fishbein MC; Berliner JA; Ardehali A
    Transplantation; 2001 Jun; 71(11):1649-56. PubMed ID: 11435978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo.
    Furukawa Y; Becker G; Stinn JL; Shimizu K; Libby P; Mitchell RN
    Am J Pathol; 1999 Dec; 155(6):1929-39. PubMed ID: 10595923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody.
    Wang H; Zhang Z; Tian W; Liu T; Han H; Garcia B; Li XC; Du C
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):115-22. PubMed ID: 24254032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.